Today, on World Diabetes Day, we emphasise the importance of open communication with patients and advocacy groups. Each November, VANGUARD partners connect, listen, and share progress with our community. This year, our partners are participating in three special patient-oriented events
A new VANGUARD article titled “The bio-artificial pancreas to treat type 1 diabetes: Perspectives from healthcare professionals in the Netherlands” has been published in the Journal of Clinical & Translational Endocrinology. This publication is openly accessible online here. In their
On 27th September, VANGUARD partners from the University of Eastern Piedmont (UPO) took part in the European Researchers’ Night 2024, the largest science outreach event in Europe. Held at the Department of Science and Technological Innovation in Alexandria, the XIX
A new VANGUARD article titled “Clinical Translation and Implementation of a Bioartificial Pancreas Therapy” has been published in Transplant Direct. This publication is openly accessible online at the following link: Transplant Direct. This study marks the first qualitative investigation on
In the last months, VANGUARD has explored the support services of Horizon Results Booster (HRB). HRB, an initiative of the European Commission, helps publicly funded projects streamline their innovation processes and maximise their impact, offering services on Portfolio Dissemination &
Last week, the VANGUARD face-to-face meeting took place in Turin, Italy, at the Molecular Biotechnology Center. The event was kindly hosted by Prof. Follenzi from the University of Eastern Piedmont and her team who gathered 21 representatives of the VANGUARD
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 874700